Percentage of Discharge Summaries That Include Medication Therapy Changes and Explanations for Changes

Identifying Attributes

Care Settings
Care Transitions
Country
Australia
Publishing Organisation
Australian Commission on Safety and Quality in Health Care (ACSQHC): National Quality Use of Medicines Indicators for Australian Hospitals (2014)
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Setting-Specific Domain
Communication

Defining Attributes

Definition

Medication therapy changes refers to changes to the patient's preadmission medication regimen that are intended to continue after discharge. Changes may include: • initiation of a new medicine • change in the dose, form, route or frequency of a medicine taken prior to admission • cessation of a medicine taken prior to admission • recommencement of a medicine that was intentionally withheld prior to admission If there are no changes to the patient's preadmission medication regimen as a result of hospital admission, this should be explicitly documented. Explanations for changes should include sufficient detail to inform future management decisions and should be explicitly documented in the discharge summary or discharge letter.

Numerator

Number of discharge summaries that include medication therapy changes and explanations for changes

Denominator

Number of discharge summaries in sample

Exclusions

None

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Collection and Reporting Attributes

Type of Data Collection
Electronic/paper chart records
Data Collection Methods

Medical records, medication charts, medication management plans or reconciliation forms, discharge summaries and discharge prescriptions. Differences between admission and discharge medicines should be assumed to represent medicine therapy changes.

Frequency of Data Collection
The National QUM Indicators are designed for data collection as part of local quality improvement activities, for use by clinicians involved in hospital medication management, especially doctors, nurses, and pharmacists. The indicators may provide evidence for accreditation purposes.
Frequency of Data Collection in Days
1
Reporting Methods

Recommended for local quality improvement processes. Not regularly reported at national level.

Reporting Frequency
Ad libitum
Reporting Frequency in Days
1
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc. (2014), National Quality Use of Medicines Indicators for Australian Hospitals. ACSQHC, Sydney www.safetyandquality.gov.au/sites/default/files/migrated/SAQ127NationalQUMIndicatorsV14-FINAL-D14-39602.pdf page 88

Technical Specifications
Link to Measurement Tools
Domain
Not Assigned
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Can the Quality Indicator be Readily Implemented at a Population Level in Australia Given its Current Data Landscape?
Implementation of this quality indicator was not assessed.
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025